Ravi Singh, Chief Research Officer from Master Capital Services Ltd., has identified three stocks for Samvat 2083 with strong potential upside over the next 12 months. According to Singh, these stocks offer potential upside of 13%, 14% and 25% respectively - Aurobindo Pharma (25%), Balkrishna Industries (14%), and Mahindra & Mahindra (13%). The expert emphasizes that Muhurat trading should be approached with a quality-first, long-term investment strategy rather than short-term speculation, recommending investors use this auspicious session to accumulate fundamentally strong companies with healthy earnings visibility and reasonable valuations.
Mirae Asset Sharekhan has released comprehensive stock recommendations for Samvat 2083, identifying 15 companies across large-cap, mid-cap and small-cap categories with potential upside of up to 37%. The brokerage's large-cap picks include Bharti Airtel with 21% upside potential (target price ₹2,350), ICICI Bank leading at 27% upside (target price ₹1,750), Larsen & Toubro offering 24% upside (target price ₹4,700), Titan Company with 22% upside (target price ₹5,287), and UltraTech Cement delivering 22% upside (target price ₹13,500). In the mid-cap segment, Welspun Corp features 24% upside potential (target price ₹3,150), while Radico Khaitan offers 21% upside (target price ₹5,012). The small-cap category is highlighted by Dee Development Engineers with the highest potential upside of 37% (target price ₹750), with Karnataka Bank and VA Tech Wabag both offering 33% upside each.
According to The Hindu BusinessLine, large-cap stocks are expected to lead the market with signs of leadership emerging, though broader market participation will be essential for sustained rallies. Amar Ambani of Yes Securities noted that the coming year will truly be a stock picker's market, with returns driven increasingly by earnings delivery rather than valuation expansion. Motilal Oswal Financial is bullish on BFSI and Capital Markets, Manufacturing, Global Outsourcing/Exports, and Consumption & Digital sectors. SMIFS has picked naval indigenisation, infrastructure and engineering, integrated logistics, digital consumption, established consumer franchises and electric public mobility. The brokerage emphasizes that defence procurement, capital expenditure, supply-chain efficiency and changing consumer preferences offer growth opportunities, with execution and capital discipline determining returns.
The Indian stock market has witnessed a sharp reversal in trend with Nifty 50 closing 2% higher after reclaiming the 25,000 levels for the first time in six months. As per The Economic Times, Nifty 50 gained nearly 7.58% over the past week while BSE Sensex surged 7.47% over the last five trading sessions. With the Diwali Muhurat trading session scheduled for November 8, Sunday, market experts emphasize that Nifty 50 and Sensex remain highly volatile during the one-hour long special session with performance mostly driven by sentiment and relatively limited participation. Singh advises investors to avoid chasing sharp intraday moves, use limit orders and deploy capital gradually, focusing on quality businesses and long-term wealth creation rather than treating Muhurat trading as an opportunity for aggressive short-term bets.
Balkrishna Industries and Aurobindo Pharma have fixed dividend record dates for the coming week, adding to their investment appeal. According to The Economic Times, Balkrishna Industries shares closed 0.18% lower at ₹2,406.90 per share with the company's board announcing ₹4 per equity share dividend and fixing November 11 as the record date. Aurobindo Pharma shares closed 0.49% higher at ₹1,797 per share with an MCAP of ₹1,03,395.41 crore and has delivered 57.56% return in one year. The company has announced ₹11 per share dividend with face value of Re 1 each, also with November 11 as the record date.
